Robust Inactivation of the Yellow Fever Virus 17D Strain Can be Achieved Using Amotosalen and UVA Light for Pathogen Reduction Treatment (PRT) of Platelet Components

被引：0

|

作者：

Laughhunn, Andrew ^{[1
]}

Maria, Felicia Santa ^{[1
]}

Girard, Yvette ^{[1
]}

Bringmann, Peter ^{[1
]}

Lanteri, Marion ^{[2
]}

Stassinopoulos, Adonis ^{[2
]}

机构：

[1] Cerus Corp, Dept Microbiol, Concord, CA USA

[2] Cerus Corp, Sci Affairs Dept, Concord, CA USA

来源：

TRANSFUSION | 2017年 / 57卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

CP358

引用

收藏

页码：201A / 202A

页数：2

相关论文

共 3 条

[1] Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen-reduction technology
Girard, Yvette A.
Santa Maria, Felicia
Lanteri, Marion C.
[J]. TRANSFUSION, 2020, 60 (03) : 622 - 627
[2] Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections
Neyts, J
Meerbach, A
McKenna, P
DeClercq, E
[J]. ANTIVIRAL RESEARCH, 1996, 30 (2-3) : 125 - 132
[3] Robust Inactivation of Mayaro Virus in Platelet Concentrates and Red Blood Cells Using Nucleic Acid Targeting Pathogen Reduction Technologies (PRT)
Maria, Felicia Santa
Laughhunn, Andrew
Girard, Yvette
Bringmann, Peter
Lanteri, Marion
Stassinopoulos, Adonis
[J]. TRANSFUSION, 2017, 57 : 47A - 48A